[SEOUL] South Korea's Kospi stock index edged higher on Friday on bargain hunting after losses in the previous session, though gains were limited by foreigners' sell-off. The Korean won held steady while the benchmark bond yield rose.South Korea's biggest drugmaker Celltrion and its affiliates, Celltrion HealthCare and Celltrion Pharm , jumped in expectation of improved profitability as the company begins to produce new biosimilar medication, Remsima SC.
In offshore trading, the won was quoted at 1,136.6 per U.S. dollar, unchanged from the previous day, while in one-year non-deliverable forward trading its one-month contract was quoted at 1,135.3 per dollar. The Kospi has risen 8.59 per cent so far this year, and gained 2.2 per cent in the previous 30 trading sessions.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessTimes - 🏆 15. / 51 Read more »